A2ML1 Inhibits Esophageal Squamous Cell Carcinoma Progression and Serves as a Novel Prognostic Biomarker
Studies have established a correlation between α2-macroglobulin-like 1 (A2ML1) and the prognosis of lung, pancreatic, and breast cancers; however, research on its involvement in the pathogenesis of esophageal carcinoma remains limited. Therefore, in this study, we aimed to investigate the role of A2...
Saved in:
| Main Authors: | Xiaoyun Zhang, Chaogui Tang, Jianchun Lian, Yuzhang Jiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2023/5557546 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TIMP4 serves as a novel potential prognostic biomarker for oral squamous cell carcinoma
by: Lian Zhou, et al.
Published: (2025-02-01) -
FAP Serves as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma
by: Zhanpeng Liao, et al.
Published: (2024-01-01) -
SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma
by: Liming Zhang, et al.
Published: (2024-11-01) -
A prognostic nomogram that includes MPV in esophageal squamous cell carcinoma
by: Qiao He, et al.
Published: (2023-10-01) -
IL-6 is a prognostic biomarker in patients with advanced esophageal squamous cell carcinoma received with PD-1 inhibitors
by: Ping Huang, et al.
Published: (2025-05-01)